An interesting week for the neuromodulation field, where Nalu Medical closed $50 million growth funding. Surgical robotics is also on the uptake, with Microbot Medical closing $92 million in a stock sale. With acquisitions, growth funding, and seed rounds all in the mix, the recent funding activities indicate a robust market.
Avanos Medical acquires Nexus Medical to strengthen nutrition and medication delivery in critical care
Avanos Medical, a leading medical technology company, today announced the acquisition of Nexus Medical, LLC, a privately held medical device company based in Lenexa, Kansas.
The acquisition adds complementary technology to Avanos’ Specialty Nutrition Systems business and reinforces the company’s focus on safe, reliable therapy delivery for the neonatal patient population.
CEO David Pacitti
Last week’s tracker: Ronovo Surgical, Noxilizer, and more
SAM Medical expands emergency medical offering with strategic acquisition of TyTek Medical
SAM Medical, a leading provider of pre-hospital emergency medical products, announced the acquisition of TyTek Medical, part of the TyTek Group. TyTek Medical is a globally known, leading provider of chest decompression needles.
The acquisition of TyTek Medical marks a significant expansion of SAM Medical’s proprietary offering of emergency medical products, further solidifying its leadership position in the emergency medical market.
CEO Jim Seidel
Microbot Medical to raise over $92M from stock sale
Microbot Medical said investors agreed to exercise outstanding preferred investment options that could generate up to $92.2 million in gross proceeds. The company expects about $25.2 million from the first closing on Sept. 16, and $4 million from a second closing by Oct. 15.
The remaining $63 million could come from new short-term series J preferred investment options if they are exercised in full. The company said there is no assurance those options will be exercised.
CEO Harel Gadot
Nalu Medical picks up $50M in growth funding
Trinity Capital announced it committed up to $50 million in growth funding to neurostimulation technology developer Nalu Medical. Carlsbad, California–based Nalu offers spinal cord stimulation and peripheral nerve stimulation (PNS) technology.
It designed its offerings to treat patients with chronic neuropathic pain. It delivers gentle electrical pulses to the nervous system to modulate pain signals before they reach the brain.
President and CEO Tom West
Peerbridge Health closes $7m funding to support its Cor MDx cardiac wearable
Peerbridge Health closed its latest fundraising round and submitted its next-generation wearable, the Cor MDx™, for FDA 510(k) clearance. The latest funding round raised $7M and will support Peerbridge’s commercial rollout of its latest generation product.
Additionally, Peerbridge Health has appointed Dan Reuvers, a medical-technology executive with decades of leadership experience, to its Board of Directors, and has expanded its sales team across three regions.
CEO Chris Darland
Virtual Vision Health closes a $1m seed round for Virtual Eye device
Virtual Vision Health raised a $1 million seed round led by GOVO Venture Partners and including individual investors. The company is GOVO Ventures’ 12th portfolio investment since the launch of GOVO’s inaugural venture fund in January of 2023.
As part of GOVO’s $500,000 investment in Virtual Vision, GOVO General Partner Brian D’Ambrosio will join Virtual Vision’s Board of Advisors.
CEO Matteo Ziff
